The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Trieu Vuong since 2017.
This trader's CIK number is 1587074.
At the time of last reporting, Trieu Vuong was the CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc.. (stock ticker symbol OTLC).
Also see all insider trading activities at Oncotelic Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | OTLC | 545,581 | $10,703 | 0 | $0 | 0 | $0 |
| 2024 | OTLC | 798,499 | $18,656 | 0 | $0 | 0 | $0 |
| 2023 | OTLC | 1,226,888 | $35,489 | 0 | $0 | 0 | $0 |
| 2022 | OTLC | 410,000 | $25,520 | 0 | $0 | 0 | $0 |
| 2020 | OTLC | 53,500 | $9,955 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | MRNA | 894,568 | $262,649 | 0 | $0 | 0 | $0 |
1. Oncotelic Therapeutics, Inc. (OTLC)
2. Nastech Pharmaceutical Co Inc (MRNA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-08 | OTLC | Buy | 94,736 | .01 | 473 |
| 2025-07-10 | OTLC | Buy | 104,000 | .01 | 520 |
| 2025-07-09 | OTLC | Buy | 1 | .01 | 0 |
| 2025-01-29 | OTLC | Buy | 183,066 | .03 | 5,125 |
| 2025-01-30 | OTLC | Buy | 100,003 | .03 | 2,800 |
| 2025-01-31 | OTLC | Buy | 63,775 | .03 | 1,785 |
| 2024-11-22 | OTLC | Buy | 298,499 | .03 | 8,656 |
| 2024-08-23 | OTLC | Buy | 500,000 | .02 | 10,000 |
| 2023-06-28 | OTLC | Buy | 75,000 | .03 | 1,950 |
| 2023-06-29 | OTLC | Buy | 425,000 | .02 | 8,925 |
| 2023-06-16 | OTLC | Buy | 100,000 | .03 | 2,600 |
| 2023-06-14 | OTLC | Buy | 400,000 | .03 | 13,200 |
| 2023-05-26 | OTLC | Buy | 126,888 | .03 | 4,314 |
| 2023-05-02 | OTLC | Buy | 100,000 | .04 | 4,500 |
| 2022-12-06 | OTLC | Buy | 120,000 | .05 | 6,000 |
| 2022-12-06 | OTLC | Buy | 120,000 | .05 | 6,000 |
| 2022-11-22 | OTLC | Buy | 70,000 | .08 | 5,600 |
| 2022-09-26 | OTLC | Buy | 20,000 | .07 | 1,360 |
| 2022-08-25 | OTLC | Buy | 80,000 | .08 | 6,560 |
| 2020-11-19 | MATN | Buy | 50,500 | .19 | 9,595 |
| 2020-03-26 | MATN | Buy | 3,000 | .12 | 360 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-09 | MRNA | Buy | 10,000 | .39 | 3,900 |
| 2017-06-07 | MRNA | Buy | 2,500 | .38 | 950 |
| 2017-06-08 | MRNA | Buy | 20,000 | .39 | 7,800 |
| 2017-02-06 | MRNA | Buy | 862,068 | .29 | 249,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Trieu Vuong (CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.